| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |